1. Guideline-directed therapies reduce risk.

The challenge is not whether these therapies matter, but whether they are identified, documented, communicated, and implemented consistently.

2. Patients are clinically complex.

Multiple conditions, incomplete laboratory data, and fragmented clinical information create implementation friction in routine practice.

3. Pharmacists need scalable workflow support.

Pharmacists are well positioned to identify optimization opportunities, but they need clinically trustworthy tools that fit real workflow.

4. Health systems need measurable implementation.

Recommendations alone are not enough. Systems need follow-up, measurement, and learning infrastructure.